Pfizer and Arvinas to Develop and Commercialize Estrogen Receptor Targeting Breast Cancer July 22, 2021 Auto Bot News 0 The companies collaborate to develop and commercialize ARV-471, an investigational oral PROTAC (proteolysis targeting chimeras) estrogen receptor protein degrader.